证券记录 · 已归档季度
COO
The Cooper Companies, Inc. · Healthcare · Medical - Instruments & Supplies
22被追踪持有人
-1Δ持有人
84.49M持有股份
$5.79B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -4.3% ·
股份流向 +5.3% ·
净新建仓位 -9.1%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 151 | +2 | 135.05M | $9.70B | +8 | −5 |
| Q1 2026 | 151 | +1 | 132.75M | $9.51B | +6 | −6 |
| Q4 2025 | 149 | -1 | 147.94M | $12.12B | +1 | −1 |
| Q3 2025 | 22 | -1 | 84.49M | $5.79B | — | −2 |
| Q2 2025 | 21 | 0 | 75.38M | $5.36B | +1 | −1 |
| Q1 2025 | 18 | -4 | 34.09M | $2.87B | — | −4 |
| Q4 2024 | 22 | +2 | 30.60M | $2.81B | +2 | — |
| Q3 2024 | 19 | +3 | 19.38M | $2.14B | +3 | — |
| Q2 2024 | 16 | — | 16.68M | $1.46B | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 23.97M | -1.1% | $1.64B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (被动) | 15.32M | -0.8% | $1.05B | 0.0% | ▼ Trim | 2 | SEC ↗ ×19 |
| 3 | Capital World Investors ✦ | 10.55M | +25.7% | $723.42M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (被动) | 8.59M | -0.8% | $588.69M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.18M | +332.9% | $424.04M | 0.1% | ▲ Add | 6 | SEC ↗ ×8 |
| 6 | Geode Capital Management ✦ (被动) | 5.30M | +1.9% | $362.11M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | T. Rowe Price ✦ | 3.80M | -42.0% | $260.34M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | JPMorgan Chase ✦ | 2.75M | — | $188.74M | 0.0% | n/c | 1 | SEC ↗ ×28 |
| 9 | Millennium Management ✦ | 2.18M | +11.6% | $149.32M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 10 | Morgan Stanley ✦ | 2.11M | — | $144.75M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 11 | D. E. Shaw & Co. ✦ | 923.40K | +68.8% | $63.31M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 670.00K | +28.4% | $45.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 508.60K | — | $34.87M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 14 | AQR Capital Management ✦ | 476.40K | +423.0% | $32.58M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 15 | Adage Capital Partners ✦ | 459.66K | +151.0% | $31.51M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 207.33K | -4.9% | $14.21M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 17 | Citadel Advisors ✦ | 142.50K | -64.1% | $9.77M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | Gotham Asset Management ✦ | 115.82K | +873.6% | $7.94M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 92.34K | -85.0% | $6.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 81.27K | +4.2% | $5.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 44.00K | 0.0% | $3.02M | 0.0% | Held | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 6.86K | +5.3% | $470,253 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $35.06M | 曾为 0.0% |
| Glenview Capital | $19.97M | 曾为 0.6% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 664 持有人, 203.43M 股份, $13.35B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Sep 16
Kurzius Lawrence Erik
Director · 10.00K 股 @ 54.93 · $549,320
Sep 14
Kurzius Lawrence Erik
Director · 10.00K 股 @ 53.91 · $539,150
Sep 14
Rosebrough Walter M Jr
Director · 3.00K 股 @ 54.29 · $162,870
Sep 11
Rosebrough Walter M Jr
Director · 7.00K 股 @ 54.11 · $378,770
Sep 11
Keel Paul A
Director · 4.70K 股 @ 53.18 · $250,000
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据